Abstract： Objective: To evaluate the diagnostic value of multi-parametric MRI for early prostate cancer. Methods: One hundred patients with prostatic diseases were scanned with MRI, all cases were pathological diagnosis as the gold standard, and they underwent T2WI, DWI and DCEI. Four protocols were formed by combination of above three technologies: T2WI (protocol 1), T2WI+DWI(protocol 2), T2WI+DCEI(protocol 3), T2WI+DWI+DCEI(protocol 4). The image data was diagnosed and made contrast with pathological findings. The AUC value of each protocol in the diagnosis of prostate cancer was compared with Z-test, and the sensitivity, specificity and accuracy for each protocol were calculated. Results: In the four protocols, the sensitivity, specificity and accuracy for protocol 4 in the diagnosis of prostate cancer were the highest(92.6%, 88.9% and 90%), the sensitivity, specificity and accuracy for protocol 1 were the lowest(68.5%, 63.0% and 66%). The AUC value of 4 protocols in descending order: protocol 4(0.916), protocol 2(0.908), protocol 3(0.870) and protocol 1(0.697). There were significant differences in AUC values between protocol 1 and 2, protocol 1 and 3, protocol 1 and 4(P＜0.05). There were not significant differences in AUC values between protocol 2 and 3, protocol 2 and 4, protocol 3 and 4(P＞0.05). Conclusion: T2WI+DWI, T2WI+DCEI and T2WI+DWI+DCEI have highly diagnostic value for early prostate cancer, the clinical value of T2WI+DWI is higher than that of T2WI+DCEI, and T2WI+DWI+DCEI is the best diagnostic efficiency.
章绪辉，梁 文，全显跃，张序昌，林 婷. 多模态MRI技术对早期前列腺癌的应用研究[J]. 中国临床医学影像杂志, 2017, 28(2): 116-119.
ZHANG Xu-hui, LIANG Wen, QUAN Xian-yue, ZHANG Xu-chang, LIN Ting . Application of multi-parametric magnetic resonance imaging in the diagnosis of early prostate cancer. JOURNAL OF CHINA MEDICAL IMAGING, 2017, 28(2): 116-119.
[1]韩苏军，张思维，陈万青，等. 中国前列腺癌发病现状和流行趋势分析[J]. 临床肿瘤学杂志，2013，18（4）：330-334.
[2]沈钓康，赵文露，杨毅，等. 1.5T MR功能成像序列联合T2WI对前列腺癌筛查的临床价值[J]. 中华放射学杂志，2014，48（1）：38-42.
[3]Styles C, Ferris N, Mitchell C, et al. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology[J]. J Med Imaging Radiat Oncol, 2014, 58(4): 439-448.
[4]Li CM, Chen M, Li S, et al. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0T[J]. Acta Radiologica, 2014, 55(2): 239-247.
[5]Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012[J]. Eur Radiol, 2012, 22(4): 747-757.
[6]李春媚，陈敏，李飒英，等. 前列腺癌的MRI诊断：T2WI、DWI、MRS及其综合分析[J]. 磁共振成像，2010，1（4）：257-263.
[7]Shimizut T, Nishie A, Ro T, et al. Prostate cancer detection: the value of performing an MRI before a Biopsy[J]. Acta Radiologica, 2009, 50(9): 1080-1088.
[8]Turkbey B, Bernardo M, Merino MJ, et al. MRI of localized prostate cancer: coming of age in the PSA era[J]. Diagn Interv Radiol, 2012, 18(1): 34-45.
[9]Schimmoller L, Quentin M, Arsov C, et al. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy[J]. Eur Radiol, 2014, 24(10): 2583-2589.
[10]张永胜，陈瑶，陈祖华，等. MRI多参数成像对前列腺癌诊断价值的研究[J]. 浙江临床医学，2014，36（14）：1224-1227.
